EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptome immune-regulatory differences between leprosy patients and type 1 reaction patients, before onset of symptoms

Wilian Correa-Macedo, Monica Dallmann-Sauer, Marianna Orlova, Jeremy Manry, Vinicius M Fava, Nguyen Thu Huong, Nguyen Ngoc Ba, Nguyen Van Thuc, Vu Hong Thai, Erwin Schurr iD

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0011866 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Wilian Correa-Macedo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Leprosy, Mycobacterium leprae, Transcriptome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, Digital Research Alliance of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leprosy is a chronic disease of the skin and peripheral nerves caused by Mycobacterium leprae . A major public health and clinical problem are leprosy reactions, which are inflammatory episodes that often contribute to nerve damage and disability. Type I reversal reactions (T1R) can occur after microbiological cure of leprosy and affect up to 50% of leprosy patients. Early intervention to prevent T1R and, hence, nerve damage, is a major focus of current leprosy control efforts. In a prospective study, we enrolled and collected samples from 32 leprosy patients before the onset of T1R. Whole blood aliquots were challenged with M . leprae sonicate or media and total RNA was extracted. After a three-year follow-up, the transcriptomic response was compared between cells from 22 patients who remained T1R-free and 10 patients who developed T1R during that period. Our analysis focused on differential transcript (i.e. isoform) expression and usage. Results showed that, at baseline, cells from T1R-destined and T1R-free subjects had no main difference in their transcripts expression and usage. However, the cells of T1R patients displayed a transcriptomic immune response to M . leprae antigens that was significantly different from the one of cells from leprosy patients who remained T1R-free. Transcripts with significantly higher upregulation in the T1R-destined group, compared to the cells from T1R-free patients, were enriched for pathways and GO terms involved in response to intracellular pathogens, apoptosis regulation and inflammatory processes. Similarly, transcript usage analysis pinpointed different transcript proportions in response to the in-vitro challenge of cells from T1R-destined patients. Hence, transcript usage in concert with transcript expression suggested a dysregulated inflammatory response including increased apoptosis regulation in the peripheral blood cells of T1R-destined patients before the onset of T1R symptoms. Combined, these results provided detailed insight into the pathogenesis of T1R.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeprosyMycobacterium lepraeTranscriptomeHumansFemaleMaleAdultProspective StudiesMiddle AgedYoung AdultAged

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada.
  • Program in Infectious Diseases and Global Health, The Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.
  • McGill International TB Centre, McGill University, Montréal, Québec, Canada.
  • Departments of Human Genetics and Medicine, Faculty of Medicine and Health Science, McGill University; Montreal, Québec, Canada.
  • Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.
  • University of Paris, Imagine Institute, Paris, France.

ORCID-Profile: Erwin Schurr

Förderung

  • Canadian Institutes of Health Research
  • Digital Research Alliance of Canada

Zitieren

APA

Correa-Macedo, W., Dallmann-Sauer, M., Orlova, M., Manry, J., Fava, V. M., Huong, N. T., Ba, N. N., Van Thuc, N., Thai, V. H., & Schurr, E. (2024). Transcriptome immune-regulatory differences between leprosy patients and type 1 reaction patients, before onset of symptoms. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011866

Vancouver

Correa-Macedo W, Dallmann-Sauer M, Orlova M, Manry J, Fava VM, Huong NT, et al. Transcriptome immune-regulatory differences between leprosy patients and type 1 reaction patients, before onset of symptoms. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0011866

BibTeX
@article{CorreaMacedo2024,
  author = {Correa-Macedo, Wilian and Dallmann-Sauer, Monica and Orlova, Marianna and Manry, Jeremy and Fava, Vinicius M and Huong, Nguyen Thu and Ba, Nguyen Ngoc and Van Thuc, Nguyen and Thai, Vu Hong and Schurr, Erwin},
  title = {Transcriptome immune-regulatory differences between leprosy patients and type 1 reaction patients, before onset of symptoms},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0011866}
}
Kostenlos starten →